Machine Learning

A new therapy for a rare blood cancer gets a major boost from the FDA, offering hope for thousands of myelofibrosis patients with limited options.

A new journal issue reveals how venture capital, advanced clinical insights, and patient-centered drug design are creating a new era in heart failure care.

With a new CFO known for billion-dollar deals and a promising gout drug, Crystalys Therapeutics is gearing up for a pivotal run at the global market.

Digital.ai's new platform promises to slash costs and boost safety for Android Auto and Apple CarPlay development, tackling a major industry bottleneck.

Portable tissue oxygen monitors, forged in US military R&D, are now in Ukraine to help medics make life-or-limb decisions in real time.

A new, self-administered RNA therapy for hereditary angioedema gains EU approval, promising fewer attacks and greater freedom for thousands of patients.

With a $150M+ capital raise and a top cancer immunologist on board, the T1D Fund is making a strategic play to shift from managing T1D to curing it.

Fintech firm launches a new system using AI to help financial institutions manage complex annuity portfolios, turning regulatory burdens into opportunities.

Industrial giant Copeland acquires AI SaaS firm Bueno Analytics, aiming to slash building emissions and transform its business model from hardware to smart services.

Jabra's new Evolve3 headsets merge pro-grade audio and AI with a sleek, boomless design, aiming to be the one headset for both work and life.

The EdTech firm is launching 'CreatAI' learning and a suite of new robotics kits, aiming to make advanced AI concepts accessible in today's classrooms.

Volvo Group will showcase its future strategy at its June Capital Markets Day, with a focus on next-gen tech and reassuring investors of its growth path.

With $35.1M in new funding, Infinitopes is launching a human trial for its AI-designed vaccine aimed at preventing oesophageal cancer recurrence.

Engineering giant Ramboll partners with tech specialist Acutro, fusing predictive AI into building design for a new era of sustainability and efficiency.

Endace's new OSm 7.3 update delivers a massive search performance boost and deep API integration, seeking to make packet capture an everyday security tool.

New research reveals a perfect storm hitting US manufacturing, as leaders grapple with a critical labor gap, economic volatility, and shifting investments.

HT Vet's new VISTA iQ uses AI to screen dog lumps in 40 seconds, aiming to save lives and transform the financial health of veterinary practices.

A new report reveals a leaner U.S. marketing job market. More companies are hiring, but for fewer, more senior roles, leaving new grads behind.

Raise's strategic acquisition of supplier marketplace Murmur signals a major shift in managing the growing contingent workforce for greater agility and control.

BioAge Labs is developing an oral drug for diabetic macular edema, a breakthrough that could end the need for frequent, invasive eye injections for millions.